Uridine-5′-Triphosphate Trisodium Salt

Application Notes

UTP has been used as a P2 receptor activator to study its effects on proton efflux in MC3T3-E1 and UMR-106 cells. UTP has also been studied in combination with amiloride hydrochloride in nebulizer solutions for treating cystic fibrosis.

Usage Statement

Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.

SKU	02191230-CF
Alternate Names	UTP-Na; UTP Trisodium
Application Notes	UTP has been used as a P2 receptor activator to study its effects on proton efflux in MC3T3-E1 and UMR-106 cells. UTP has also been studied in combination with amiloride hydrochloride in nebulizer solutions for treating cystic fibrosis.
Base Catalog Number	191230
Beilstein Registry Number	3585234
Biochemical Physiological Actions	P2Y receptor agonist.
CAS #	19817-92-6
EC Number	243-347-5
Format	Powder
Molecular Formula	C9H12N2O15P3Na3
Molecular Weight	550.085 g/mol
Personal Protective Equipment	Eyeshields, Gloves, respirator filter
Purity	>90%
Usage Statement	Unless specified otherwise, MP Biomedical's products are for research or further manufacturing use only, not for direct human use. For more information, please contact our customer service department.
UV Visible Absorbance	OD250/OD260 0.75 ± 0.05 ; OD280/OD260 0.40 ± 0.05